Anetumab

• Description:

  Anetumab (Anti-MSLN Antibody) is a fully humanized anti mesothelin (MSLN) IgG1 antibody. Anetumab (Anti-MSLN Antibody) can be used to synthesize the ADC molecule Anetumab ravtansine (HY-141606) . Anetumab (Anti-MSLN Antibody) can be used for the research of cancer[1].

• Product Name Alternative:

  Anti-MSLN Antibody

• UNSPSC:

  12352203

• Target:

  ADC Antibody; Mesothelin

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Antibody-drug Conjugate/ADC Related; Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anetumab.html

• Purity:

  98.78

• Solubility:

  10 mM in DMSO

• Smiles:

  [Anetumab]

• Molecular Weight:

  (143.66 kDa)

• References & Citations:

  [1]Golfier S, et al. Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect. Mol Cancer Ther. 2014 Jun;13 (6) :1537-48.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  Phase 2

• CAS Number:

  [1954758-84-9]